Skip to main content
Toggle navigation
Login
Search
Home
Final Program
Tweets by 2022 Annual Meeting
Home
Browse by Poster Author
Browse by Poster Author
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
R
Racha, Savitha
Johns Hopkins School of Medicine
(
89
)
Infective Endocarditis in People Who Use Drugs: A Critical Review of Guidelines
Savitha Racha
Rafeq, Rachel
Cooper University Hosptial
(
61
)
Impact of an Alcohol Withdrawal Screening and Treatment Protocol for Hospitalized Patients
Rachel Rafeq
Rajapaksha Wasala Mudiyanselage, Anusha Madushani
Boston Medical Center
(
90
)
Extended-Release Buprenorphine for Opioid Use Disorder: A Cost-Effectiveness Analysis
Anusha Madushani Rajapaksha Wasala Mudiyanselage
Ramage, Melinda
Project CARA, Mountain Area Health Education Center
(
96
)
Perinatal Opioid Use Disorder: Postpartum Access to Healthcare and Opioid Use Treatment
Melinda Ramage
Ramdin, Christine
Rutgers New Jersey Medical School
(
52
)
Services for Treatment of Chronic Pain at Residential Substance Abuse Treatment Centers
Christine Ramdin
Rangan, Pooja
Banner University Medical Center Phoenix
(
85
)
Opioid Overdoses During the 2020 COVID-19 Pandemic
Pooja Rangan
Reamy, Nanda
John Peter Smith Health Network
(
101
)
Right Treatment Right Time: ED MOUD in a Single Safety-Net Hospital System
Nanda Reamy
Regan, Susan
Massachusetts General Hospital
(
77
)
People Who Inhale Stimulants At Risk for COVID-19 and Other Injury
Susan Regan
Rennick, Andrew
University of Miami Miller School of Medicine
(
64
)
Availability of Buprenorphine-Naloxone in Outpatient Pharmacies in South Florida
Andrew Rennick
Rigotti, Nancy
Harvard Medical School
(
19
)
Successfully Enrolling a Prospective Cohort With Opioid Use Disorder and Serious Infections
Nancy Rigotti
Rivera, Josef
Wright State University Boonshoft School of Medicine
(
65
)
Beyond Trauma-Informed Care: Insights from a Qualitative Study
Josef Rivera
Roberts, Kate
UNC- Chapel Hill
(
94
)
In Hospital Addiction Treatment Reduces Readmissions for Patients with Related IE
Kate Roberts
Rodriguez, Claudia
Brigham and Women's Hospital/Faulkner/Harvard Medical School
(
45
)
Evaluating Disparities in Prescribing of Naloxone After Treatment of Opioid Overdose
Claudia Rodriguez
Rodriguez, Maria
University of Miami Miller School of Medicine
(
64
)
Availability of Buprenorphine-Naloxone in Outpatient Pharmacies in South Florida
Maria Rodriguez
Rodriguez, Windia
Mass General Hsopital
(
46
)
Race and Ethnicity Concordance in Recovery Coaching
Windia Rodriguez
Rohsenow, Damaris
Brown University School of Public Health
(
69
)
Circumstances Around Cigarette Use After Enforced Smoking Abstinence in an American Prison
Damaris Rohsenow
Rosenthal, Elana
University of Maryland School of Medicine
(
31
)
COVID-19 Vaccine Uptake and Attitudes Among People with OUD
Elana Rosenthal
Ruiz-Mercado, Glorimar
Boston Medical Center
(
54
)
Pre-Paid Phone Distribution to People With Substance Use Disorder
Glorimar Ruiz-Mercado
Rush, Craig
University of Kentucky
(
49
)
Comparing Outcomes of mOUD Maintenance vs. Detoxification in Pregnant Patients with OUD
Craig Rush
Rutrick, Daniel
Adams Clinical
(
83
)
Long-Term Treatment Benefit of BUP-XR for Patients Struggling to Abstain from Opioids
Daniel Rutrick
Back to Top